We use cookies to provide you with a better service. Carry on browsing if you’re happy with this or read more about our cookie policy and privacy policy.
None of the standards were met. 71% had an HbA1c measured, and in 29% the HbA1c was >8.5%.
cause of chronic cough deemed to be the underlying pathology. 40% (n=20) of patients suspected to have GORD underwent an anti-acid trial with efficacy of 71%
71 and above
This cohort recorded a total of 12,932 procedures whereby AUGIB endotherapy was delivered, corresponding to a median of 42 (IQR 21-71) per gastroenterologist
71 - 75
No significant improvement in CIR was detected in the other two groups, with changes of 68% to 71% (p=0.239) and 86% to 87% (p=0.354) for the 70-140 and
patients who took the survey were told they could have a family member, carer or friend with them when told diagnosis, against a national average of 71%